Avalo Non Operating Income Net Other from 2010 to 2024

AVTX Stock  USD 9.23  0.12  1.32%   
Avalo Therapeutics Non Operating Income Net Other yearly trend continues to be fairly stable with very little volatility. Non Operating Income Net Other will likely drop to about 4.5 M in 2024. During the period from 2010 to 2024, Avalo Therapeutics Non Operating Income Net Other regression line of annual values had r-squared of  0.32 and arithmetic mean of  5,505,289. View All Fundamentals
 
Non Operating Income Net Other  
First Reported
2010-12-31
Previous Quarter
5.1 M
Current Value
4.5 M
Quarterly Volatility
314.9 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Avalo Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avalo Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 150.1 K, Interest Expense of 5.6 M or Selling General Administrative of 11.9 M, as well as many indicators such as Price To Sales Ratio of 1.25, Dividend Yield of 0.0 or PTB Ratio of 0.33. Avalo financial statements analysis is a perfect complement when working with Avalo Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Avalo Therapeutics Correlation against competitors.
For more information on how to buy Avalo Stock please use our How to Invest in Avalo Therapeutics guide.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Avalo Stock Analysis

When running Avalo Therapeutics' price analysis, check to measure Avalo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalo Therapeutics is operating at the current time. Most of Avalo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avalo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalo Therapeutics' price. Additionally, you may evaluate how the addition of Avalo Therapeutics to your portfolios can decrease your overall portfolio volatility.